Globe Life Inc. (NYSE:GL) last week reported its latest quarterly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. Revenues of US$1.5b were in line with forecasts, although statutory earnings per share (EPS) came in below expectations at US$3.01, missing estimates by 6.1%. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

We've discovered 1 warning sign about Globe Life. View them for free.NYSE:GL Earnings and Revenue Growth May 3rd 2025

Taking into account the latest results, the consensus forecast from Globe Life's seven analysts is for revenues of US$6.06b in 2025. This reflects a satisfactory 3.7% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to rise 4.7% to US$13.47. In the lead-up to this report, the analysts had been modelling revenues of US$6.05b and earnings per share (EPS) of US$13.51 in 2025. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

View our latest analysis for Globe Life

The analysts reconfirmed their price target of US$141, showing that the business is executing well and in line with expectations. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Globe Life, with the most bullish analyst valuing it at US$188 and the most bearish at US$111 per share. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

Of course, another way to look at these forecasts is to place them into context against the industry itself. The period to the end of 2025 brings more of the same, according to the analysts, with revenue forecast to display 5.0% growth on an annualised basis. That is in line with its 4.7% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 5.2% annually. It's clear that while Globe Life's revenue growth is expected to continue on its current trajectory, it's only expected to grow in line with the industry itself.

Story Continues

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on Globe Life. Long-term earnings power is much more important than next year's profits. We have forecasts for Globe Life going out to 2027, and you can see them free on our platform here.

Even so, be aware that  Globe Life is showing  1 warning sign in our investment analysis, you should know about...

Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

View Comments